{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:38:48Z","timestamp":1789605528660,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["PICT 577\/2012"],"award-info":[{"award-number":["PICT 577\/2012"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["689\/2013"],"award-info":[{"award-number":["689\/2013"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["632\/2016"],"award-info":[{"award-number":["632\/2016"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.pharep.2018.09.009","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T12:38:42Z","timestamp":1537619922000},"page":"96-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8371-2633","authenticated-orcid":false,"given":"Leandro M.","family":"Velez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3498-7010","authenticated-orcid":false,"given":"Giselle A.","family":"Abruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2392-3671","authenticated-orcid":false,"given":"Mar\u00eda F.","family":"Heber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia B.","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0005","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/JOE-14-0469","article-title":"Early-life nutritional effects on the female reproductive system","volume":"224","author":"Chan","year":"2015","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.pharep.2018.09.009_bib0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00003677-200307000-00008","article-title":"Energy availability, not body fatness, regulates reproductive function in women","volume":"31","author":"Loucks","year":"2003","journal-title":"Exerc Sport Sci Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.pharep.2018.09.009_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1439-0531.2010.01662.x","article-title":"Nutritional and metabolic mechanisms in the ovary and their role in mediating the effects of diet on folliculogenesis: a perspective","volume":"45","author":"Scaramuzzi","year":"2010","journal-title":"Reprod Domest Anim"},{"key":"10.1016\/j.pharep.2018.09.009_bib0020","doi-asserted-by":"crossref","first-page":"6517313","DOI":"10.1155\/2016\/6517313","article-title":"Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions","volume":"2016","author":"Vitale","year":"2016","journal-title":"PPAR Res"},{"issue":"6","key":"10.1016\/j.pharep.2018.09.009_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2174\/156802612799436669","article-title":"Biology and therapeutic applications of peroxisome proliferator- activated receptors","volume":"12","author":"Menendez-Gutierrez","year":"2012","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1677\/joe.1.06667","article-title":"Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition","volume":"189","author":"Froment","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharep.2018.09.009_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1477-7827-3-41","article-title":"Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling","volume":"3","author":"Komar","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"10.1016\/j.pharep.2018.09.009_bib0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.pharep.2018.09.009_bib0045","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1074\/jbc.M409468200","article-title":"The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis","volume":"280","author":"Yu","year":"2005","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharep.2018.09.009_bib0050","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1095\/biolreprod66.5.1531","article-title":"Localization and expression of messenger RNAs for the peroxisome proliferator-activated receptors in ovarian tissue from naturally cycling and pseudopregnant rats","volume":"66","author":"Komar","year":"2002","journal-title":"Biol Reprod"},{"issue":"20","key":"10.1016\/j.pharep.2018.09.009_bib0055","doi-asserted-by":"crossref","first-page":"17830","DOI":"10.1074\/jbc.M200186200","article-title":"Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility","volume":"277","author":"Cui","year":"2002","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharep.2018.09.009_bib0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1530\/REP-15-0041","article-title":"Effect of hyperandrogenism on ovarian function","volume":"149","author":"Velez","year":"2015","journal-title":"Reproduction"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.pharep.2018.09.009_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.pharep.2018.09.009_bib0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1463-1326.1999.00026.x","article-title":"The polycystic ovary syndrome: treatment with insulin sensitizing agents","volume":"1","author":"Iuorno","year":"1999","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.fertnstert.2012.10.017","article-title":"Prenatal hyperandrogenism and lipid profile during different age stages: an experimental study","volume":"99","author":"Heber","year":"2013","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1095\/biolreprod67.2.481","article-title":"Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: regulation by epidermal growth factor and the expression of Bcl-2-related genes","volume":"67","author":"Parborell","year":"2002","journal-title":"Biol Reprod"},{"issue":"1","key":"10.1016\/j.pharep.2018.09.009_bib0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.fertnstert.2010.07.1083","article-title":"Peroxisome proliferator-activated receptor gamma and early folliculogenesis during an acute hyperandrogenism condition","volume":"95","author":"Faut","year":"2011","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.pharep.2018.09.009_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/REP-11-0239","article-title":"Effect of androgen treatment during foetal and\/or neonatal life on ovarian function in prepubertal and adult rats","volume":"143","author":"Tyndall","year":"2012","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.pharep.2018.09.009_bib0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0185(199709)249:1<44::AID-AR6>3.0.CO;2-F","article-title":"Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles","volume":"249","author":"Everett","year":"1997","journal-title":"Anat Rec"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0110","first-page":"207","article-title":"Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose\/insulin ratio","volume":"14","author":"Beloosesky","year":"2004","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.pharep.2018.09.009_bib0115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1095\/biolreprod.102.009944","article-title":"Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist","volume":"68","author":"Irusta","year":"2003","journal-title":"Biol Reprod"},{"issue":"7","key":"10.1016\/j.pharep.2018.09.009_bib0120","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0090-9556(24)15347-0","article-title":"Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans","volume":"28","author":"Cox","year":"2000","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.pharep.2018.09.009_bib0125","doi-asserted-by":"crossref","first-page":"e37658","DOI":"10.1371\/journal.pone.0037658","article-title":"Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure","volume":"7","author":"Amalfi","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.pharep.2018.09.009_bib0130","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/molehr\/5.11.1011","article-title":"The involvement of nitric oxide in corpus luteum regression in the rat: feedback mechanism between prostaglandin F(2alpha) and nitric oxide","volume":"5","author":"Motta","year":"1999","journal-title":"Mol Hum Reprod"},{"issue":"8","key":"10.1016\/j.pharep.2018.09.009_bib0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/molehr\/gal057","article-title":"The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice","volume":"12","author":"Elia","year":"2006","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"10.1016\/j.pharep.2018.09.009_bib0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3892\/mmr.2014.1895","article-title":"Expression of PPAR-gamma in adipose tissue of rats with polycystic ovary syndrome induced by DHEA","volume":"9","author":"Wang","year":"2014","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.pharep.2018.09.009_bib0145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/09513590600733357","article-title":"Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-\u03b3 gene in women with polycystic ovary syndrome","volume":"22","author":"Yilmaz","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.pharep.2018.09.009_bib0150","doi-asserted-by":"crossref","first-page":"18319","DOI":"10.1038\/srep18319","article-title":"The effect of androgens on ovarian follicle maturation: dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPAR\u03b3-dependent PTEN expression","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"issue":"33","key":"10.1016\/j.pharep.2018.09.009_bib0155","doi-asserted-by":"crossref","first-page":"22464","DOI":"10.1074\/jbc.M800842200","article-title":"PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle","volume":"283","author":"Pagel-Langenickel","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0160","first-page":"200","article-title":"Initial and cyclic recruitment of ovarian follicles","volume":"21","author":"McGee","year":"2000","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.pharep.2018.09.009_bib0165","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharep.2018.09.009_bib0170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0301-5629(91)90029-V","article-title":"Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances","volume":"17","author":"Pache","year":"1991","journal-title":"Ultrasound Med Biol"},{"issue":"5","key":"10.1016\/j.pharep.2018.09.009_bib0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2265.1994.tb01818.x","article-title":"Ovarian stromal hypertrophy in hyperandrogenic women","volume":"41","author":"Dewailly","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.pharep.2018.09.009_bib0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/09513590.2010.495797","article-title":"Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome","volume":"27","author":"Amato","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.pharep.2018.09.009_bib0190","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/molehr\/7.8.731","article-title":"The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle","volume":"7","author":"Duffy","year":"2001","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"10.1016\/j.pharep.2018.09.009_bib0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2008.08.009","article-title":"Pioglitazone reduces tumor necrosis factor-alpha serum concentration and mRNA expression of adipose tissue in hypercholesterolemic rabbits","volume":"138","author":"Wu","year":"2010","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.pharep.2018.09.009_bib0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.2006.04376.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents","volume":"101","author":"Tureyen","year":"2007","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.pharep.2018.09.009_bib0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0035-1554928","article-title":"Inflammation and human ovarian follicular dynamics","volume":"33","author":"Boots","year":"2015","journal-title":"Semin Reprod Med"},{"issue":"1","key":"10.1016\/j.pharep.2018.09.009_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2007.08.050","article-title":"Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells","volume":"426","author":"Boetkjaer","year":"2007","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.pharep.2018.09.009_bib0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.HYP.0000103629.01745.59","article-title":"Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity","volume":"43","author":"Dobrian","year":"2004","journal-title":"Hypertension"},{"issue":"4-5","key":"10.1016\/j.pharep.2018.09.009_bib0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.etp.2004.12.002","article-title":"Effects of pioglitazone on hyperglycemia-induced alterations in antioxidative system in tissues of alloxan-treated diabetic animals","volume":"56","author":"Gumieniczek","year":"2005","journal-title":"Exp Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.pharep.2018.09.009_bib0225","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/mol.106.028902","article-title":"Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2","volume":"71","author":"Kempna","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"7","key":"10.1016\/j.pharep.2018.09.009_bib0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17070999","article-title":"Pleiotropic actions of peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and future perspectives","volume":"17","author":"Lagan\u00e0","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pharep.2018.09.009_bib0235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","article-title":"PPARs: therapeutic targets for metabolic disease","volume":"26","author":"Berger","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2018.09.009_bib0240","first-page":"w13071","article-title":"Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels","volume":"140","author":"Yessoufou","year":"2010","journal-title":"Swiss Med Wkly"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018301981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018301981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:46Z","timestamp":1752611866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.09.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1734114018301981"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.09.009","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}